Trial intelligence / Profile preview

Memory, Ageing, and the Cholinergic System

DRKS00000780Phase 2Completed

Sponsor
University Hospital Cologne
Start
Mar 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of rivastigmine in cognitive disorder (CD), Mild Cognitive Impairment (MCI), sponsored by University Hospital Cologne. Started Mar 2011; status: completed.

02

Drugs

rivastigmine
03

Conditions

cognitive disorder (CD)Mild Cognitive Impairment (MCI)

Beyond the preview

Go deeper on DRKS00000780.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00000780.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call